Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more
Sakar Healthcare Limited (SAKAR) - Total Assets
Latest total assets as of September 2025: ₹4.49 Billion INR
Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) holds total assets worth ₹4.49 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sakar Healthcare Limited - Total Assets Trend (2010–2025)
This chart illustrates how Sakar Healthcare Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sakar Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Sakar Healthcare Limited's total assets of ₹4.49 Billion consist of 21.4% current assets and 78.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹1.02 Million | 0.1% |
| Accounts Receivable | ₹307.23 Million | 7.4% |
| Inventory | ₹435.92 Million | 10.5% |
| Property, Plant & Equipment | ₹3.21 Billion | 77.3% |
| Intangible Assets | ₹46.11 Million | 1.1% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Sakar Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sakar Healthcare Limited's current assets represent 21.4% of total assets in 2025, a decrease from 30.9% in 2010.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2025, down from 0.6% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is property, plant & equipment at 77.3% of total assets.
Sakar Healthcare Limited Competitors by Total Assets
Key competitors of Sakar Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Sakar Healthcare Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Sakar Healthcare Limited generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Sakar Healthcare Limited generates $ 4.21 in net profit.
Sakar Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.08 | 1.12 | 1.35 |
| Quick Ratio | 0.57 | 0.65 | 0.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹72.46 Million | ₹ 89.35 Million | ₹ 75.39 Million |
Sakar Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Sakar Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.40 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 6.8% |
| Total Assets | ₹4.15 Billion |
| Market Capitalization | $31.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sakar Healthcare Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sakar Healthcare Limited's assets grew by 6.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sakar Healthcare Limited (2010–2025)
The table below shows the annual total assets of Sakar Healthcare Limited from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹4.15 Billion | +6.84% |
| 2024-03-31 | ₹3.89 Billion | +15.56% |
| 2023-03-31 | ₹3.36 Billion | +25.61% |
| 2022-03-31 | ₹2.68 Billion | +50.61% |
| 2021-03-31 | ₹1.78 Billion | +54.44% |
| 2020-03-31 | ₹1.15 Billion | +16.66% |
| 2019-03-31 | ₹986.85 Million | +21.68% |
| 2018-03-31 | ₹811.00 Million | +14.89% |
| 2017-03-31 | ₹705.87 Million | +38.11% |
| 2016-03-31 | ₹511.10 Million | +1.86% |
| 2015-03-31 | ₹501.75 Million | -4.13% |
| 2014-03-31 | ₹523.37 Million | +4.48% |
| 2013-03-31 | ₹500.94 Million | +0.35% |
| 2012-03-31 | ₹499.20 Million | +2.11% |
| 2011-03-31 | ₹488.89 Million | +9.29% |
| 2010-03-31 | ₹447.35 Million | -- |